We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-13.54%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$1.83B
AUM Growth
-$332M
Cap. Flow
-$24.8M
Cap. Flow %
-1.35%
Top 10 Hldgs %
18.11%
Holding
3,058
New
40
Increased
272
Reduced
460
Closed
69

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$4.16M
2
EGN
Energen
EGN
+$3.33M
3
LW icon
Lamb Weston
LW
+$3.12M
4
KEYS icon
Keysight
KEYS
+$3.12M
5
JKHY icon
Jack Henry & Associates
JKHY
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 13.37%
2 Financials 12.11%
3 Industrials 9.9%
4 Healthcare 9.85%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTIC
2926
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3K ﹤0.01%
4,450
IMH
2927
DELISTED
Impac Mortgage Holdings Inc.
IMH
$3K ﹤0.01%
665
ACWI icon
2928
iShares MSCI ACWI ETF
ACWI
$33.4B
$2K ﹤0.01%
42
-3
-7% -$206
ARL icon
2929
American Realty Investors
ARL
$246M
$2K ﹤0.01%
174
BBGI icon
2930
Beasley Broadcasting Group
BBGI
$39.3M
$2K ﹤0.01%
21
BBH icon
2931
VanEck Biotech ETF
BBH
$430M
$2K ﹤0.01%
20
BWX icon
2932
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$2K ﹤0.01%
89
+1
+1% +$27
CIX icon
2933
Comp X International
CIX
$391M
$2K ﹤0.01%
124
CLSD
2934
DELISTED
Clearside Biomedical
CLSD
$2K ﹤0.01%
121
DNTH icon
2935
Dianthus Therapeutics
DNTH
$6.16B
$2K ﹤0.01%
21
FBIO icon
2936
Fortress Biotech
FBIO
$90M
$2K ﹤0.01%
177
IBB icon
2937
iShares Biotechnology ETF
IBB
$9.89B
$2K ﹤0.01%
30
IYM icon
2938
iShares US Basic Materials ETF
IYM
$1.02B
$2K ﹤0.01%
30
LVO icon
2939
LiveOne
LVO
$53.5M
$2K ﹤0.01%
40
METC icon
2940
Ramaco Resources Class A
METC
$685M
$2K ﹤0.01%
444
MOG.A icon
2941
Moog Inc Class A
MOG.A
$13.3B
$2K ﹤0.01%
29
-2,677
-99% -$212K
NL icon
2942
NLI Holdings
NL
$318M
$2K ﹤0.01%
532
OIH icon
2943
VanEck Oil Services ETF
OIH
$1.97B
$2K ﹤0.01%
10
PBE icon
2944
Invesco Biotechnology & Genome ETF
PBE
$359M
$2K ﹤0.01%
45
PRPL icon
2945
Purple Innovation
PRPL
$30.2M
$2K ﹤0.01%
14
SCPH
2946
DELISTED
scPharmaceuticals
SCPH
$2K ﹤0.01%
625
VALU icon
2947
Value Line
VALU
$355M
$2K ﹤0.01%
91
VEU icon
2948
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
$2K ﹤0.01%
62
+1
+2% +$48
VRCA icon
2949
Verrica Pharmaceuticals
VRCA
$86.9M
$2K ﹤0.01%
30
YARW
2950
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
0

Similar funds

Ameritas Investment Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ameritas Investment Partners held 3,058 positions worth $1.83B, down 15% from $2.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.6%. Ameritas Investment Partners opened 40 new positions and exited 69, leaving the 3,058-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

  • Ameritas Investment Partners's largest Q4 2018 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 1,920 shares worth $2.42M.
  • Ameritas Investment Partners added most to Alerian MLP ETF in Q4 2018, an estimated $15.2M increase.
  • Ameritas Investment Partners's biggest Q4 2018 reduction was Lamb Weston, cutting an estimated $3.12M.
  • Ameritas Investment Partners fully exited Praxair Inc in Q4 2018, selling an estimated $4.16M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $1.83B portfolio in Q4 2018.
  • Ameritas Investment Partners opened 40 new positions and closed 69 in Q4 2018.
  • Ameritas Investment Partners's portfolio value fell 15% quarter-over-quarter to $1.83B.

Based on Ameritas Investment Partners's 13F filing for Q4 2018, filed 12 Feb 2019.